Transparent Payments to Healthcare Providers

Across Europe the pharmaceutical industry has committed to disclose the payments that it has made to healthcare professionals (HCPs) and organizations (HCOs) through adoption of the European Pharmaceutical Industry's HCP/HCO Disclosure Code. 

The very best clinical practice requires input and expertise from many groups: clinicians; patient organisations; academics; healthcare organisations; and those that discover and manufacture new medicines and medical technology.

Collaboration between all of these important experts results in three main benefits: 

  • Making new medicines possible in the first place; 

  • Providing vital health education to ensure that medicines are used appropriately; and 

  • Capturing real life insights into current treatments and understanding unmet medical needs. 

It's important these relationships are managed transparently to help demonstrate that the over-riding objective is to keep patients at the centre of our collective efforts. At Lilly, we value our relationship with HCPs and HCOs and fully support the European Federation of Pharmaceutical Industries and Association's (EFPIA's) commitment to publishing the details of payments and transfers of value made to them through annual disclosure reports. Examples of transfers of value may include a grant to an HCO, a consultancy fee for speaking, travel expenses, or registration fees to attend a medical education congress.

Details are reported either by individual HCP or HCO or in an aggregate manner, based on individual or organizational choice in accordance with respective country privacy laws. Reports are published annually and are available for three years with the first year of disclosure occurring in 2016 for payments and transfers of value to HCPs and HCOs made in 2015. 

About the Code 

The EFPIA Disclosure Code requires all EFPIA member companies (those within and outside of the European Union) to disclose payments and transfers of value to HCPs and HCOs. 

Data privacy requires companies to acquire consent from the HCP for the individual disclosure of his/her name with associated transfers of value. If the HCP does not grant his/her consent for the individual disclosure, Lilly will report the associated payments and transfers of value in aggregate, under an unnamed category. Consent must also be collected from an HCO in some countries. 

Please consult EFPIA's website for additional information on the Code, and direct any questions specific to Lilly's implementation of the Code to global_transparency_mailbox@lilly.com.

Disclosure Reports 

Below are links to our reports for each country publishing data in accordance with the EFPIA Disclosure Code and methodological notes that describe Lilly's methods for meeting the requirements outlined by each country (countries begin reporting in May with all countries reporting by June 30). Please note that in some countries data from all EFPIA member companies are published centrally and in these cases the link will take you to a third party website. Lilly provides this information in accordance with the EFPIA Disclosure Code and in the spirit of greater transparency (click to read our letter of certification for 2023, 2024) and 2025^Letter of certification for 2025

Country
HCP/HCO Disclosure Report
Methodological Notes
austria-flag

Austria

belgium-flag

Belgium

bosnia-and-herzegovina-flag

Bosnia and Herzegovina

2022
2023
2024^Bosnia Tansparency Payments to Healtcare Provider in 2024

2021
2022
2023
2024^Bosnia Tansparency Payments to Healtcare Provider in 2024

bulgaria-flag

Bulgaria

croatia-flag

Croatia

cyprus-flag

Cyprus

czech-republic-flag

Czech Republic

finland-flag

Finland

france-flag

France


germany-flag

Germany

greece-flag

Greece

hungary-flag

Hungary

ireland-flag

Ireland

italy-flag

Italy

latvia-flag

Latvia

lithuania-flag

Lithuania

luxembourg-flag

Luxembourg

netherlands-flag

Netherlands

norway-flag

Norway

poland-flag

Poland

romania-flag

Romania

russia-flag

Russia

2022
2023*
2024*

2022
2023*
2024*

serbia-flag

Serbia

slovakia-flag

Slovakia

slovenia-flag

Slovenia

spain-flag

Spain

sweden-flag

Sweden

switzerland-flag

Switzerland

ukraine-flag

Ukraine

united-kingdom-flag

United Kingdom

* There has been no reportable Transfers of Value to HCPs nor HCOs in this country during this year.